Rich, after 4 months of testing and research, I took the advice of consulting UR and RT regarding not doing the Brachy boost since I already had urinary retention. I was advised that it might worsen it, although it would add some power for attacking cancer. I seem to have a similar profile to you and of course, I was also interested in SBRT too. It appeared from my review of the SBRT clinical studies and various consulting physicians advice that I wasn't a good candidate for SBRT. Hypofractionated SBRT for PC was recommended for low-risk 3+3 or favorable 3+4 only. There just wasn't enough supporting evidence for me to do it. I had been considering AS at first so it wasn't that I wasn't willing to take some risks. However, my consult with MD Anderson Proton Center and their pathology interpretation of a 4+3 spooked me into requesting a 3-month Lupron shot that day. Their interpretation wasn't supported by any percentages and John Hopkins and UNM both agreed with my original 3+4=7. My RT MD seemed to change his mind but never said so. Still taking into account reoccurrence I am glad I went with the 6 months on Lupron. I have 1 1/2 months to go. Also, I went with 44 higher dose 79.2 rather than 39 at 70.2. There was a recent (8 years) clinical study comparing both with similar mortality results yet there was less reoccurrence for the higher dose. Science Daily has an easy to understand article on this, ithttps://www.sciencedaily.com/releases/2018/03/180315110643.htm Because the 44 traditional approach might lead to greater side effects I also used the SpaceOar originally recommended by MD Anderson and done by UNM RT. I also requested a cystoscopy from my UR with urethral dilation a week prior to starting RT treatment. You seem to be a comprehensive cancer center. You should be able to get everything you need right there. Take your time and feel conformable with your decision.
================
68 yrs., 9 of 44 79.2 gray treatments, PSA .012, 8.12.18, 1.42 June 18, 2018 (Lupron 5.21.18 & 8.15.18), 12.7 May 2018, 13.7 Jan. 2018, 2.1 May 2012. SpaceOar 9.6.18, testosterone <.7, 8.15.18, Tot Mayo 19 ng .17 testosterone Free 6.18.18, Gleason 3+4=7 involving 15% of the right apex and 15% of the right mid, 3+3=6 prostate cancer involving 5% of the left base. Pathology interpretations by John Hopkins, UNM Cancer, and SF Path 3+4=7 or 4+3=7 MD Anderson Proton Center w/o %. T3 MRI 1.8 lesion left side 5P, Neg. Bone Scan. Prolaris test 3.5 consistent with intermediate and a PTEN test negative. Father PC age 78 RT & ADT now 93 yrs. Neurogenic bladder due to lumbar disk disease and recurrent bladder neck contracture with urinary retention man. 20 years doing catheterizations. TURP & scaring 2003, Finasteride 5 milligrams daily since 2002.
Post Edited (SantaZia) : 10/6/2018 8:14:28 AM (GMT-6)